Search research articles
Contact Us
Filters
Showing results (61-70 of 202) with videos related to
Page
of 21
Sort By:
Human Pathology
|
May 16, 2018
Small cell carcinoma of the urinary bladder: a clinicopathological and immunohistochemical analysis of 81 cases
Gang Wang, Li Xiao, Miao Zhang, et al.
European Urology
|
February 29, 2016
Papillary Recurrence of Bladder Cancer at First Evaluation after Induction Bacillus Calmette-Guérin Therapy: Implication for Clinical Trial Design
Chinedu O Mmeje, Charles C Guo, Jay B Shah, et al.
BJU International
|
December 2, 2021
Should patients with non-muscle-invasive bladder cancer discontinue fibrin clot inhibitors during bacille Calmette-Guérin?
Niyati Lobo, Patrick J Hensley, Kelly K Bree, et al.
Cancer
|
June 24, 2010
A multiplexed, particle-based flow cytometric assay identified plasma matrix metalloproteinase-7 to be associated with cancer-related death among patients with bladder cancer
Robert S Svatek, Jay B Shah, Jinliang Xing, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
April 22, 2015
Mitochondrial DNA Content as Risk Factor for Bladder Cancer and Its Association with Mitochondrial DNA Polymorphisms
Stephen B Williams, Yuanqing Ye, Maosheng Huang, et al.
Urology
|
September 19, 2006
Clinical model of lifetime cost of treating bladder cancer and associated complications
Elenir B C Avritscher, Catherine D Cooksley, H Barton Grossman, et al.
The Journal of Urology
|
October 16, 2007
Differences in survival among patients with sarcomatoid carcinoma, carcinosarcoma and urothelial carcinoma of the bladder
Jonathan L Wright, Peter C Black, Gordon A Brown, et al.
American Journal of Clinical Pathology
|
November 13, 2014
Uroplakin II is a more sensitive immunohistochemical marker than uroplakin III in urothelial carcinoma and its variants
Wenping Li, Yu Liang, Michael T Deavers, et al.
International Journal of Cancer
|
December 14, 2017
Dietary patterns and risk of recurrence and progression in non-muscle-invasive bladder cancer
Ellen Westhoff, Xifeng Wu, Lambertus A Kiemeney, et al.
Medicine
|
August 7, 2016
Comparison between whole mount tissue preparations and virtual tissue microarray samples for measuring Ki-67 and apoptosis indices in human bladder cancer: A cross-sectional study
Hisashi Oshiro, Bogdan A Czerniak, Kentaro Sakamaki, et al.
Page
of 21
Search research articles
Search
Showing results (61-70 of 202) with videos related to
Sort By:
Page
of 21
Human Pathology
|
May 16, 2018
Small cell carcinoma of the urinary bladder: a clinicopathological and immunohistochemical analysis of 81 cases
Gang Wang, Li Xiao, Miao Zhang, et al.
European Urology
|
February 29, 2016
Papillary Recurrence of Bladder Cancer at First Evaluation after Induction Bacillus Calmette-Guérin Therapy: Implication for Clinical Trial Design
Chinedu O Mmeje, Charles C Guo, Jay B Shah, et al.
BJU International
|
December 2, 2021
Should patients with non-muscle-invasive bladder cancer discontinue fibrin clot inhibitors during bacille Calmette-Guérin?
Niyati Lobo, Patrick J Hensley, Kelly K Bree, et al.
Cancer
|
June 24, 2010
A multiplexed, particle-based flow cytometric assay identified plasma matrix metalloproteinase-7 to be associated with cancer-related death among patients with bladder cancer
Robert S Svatek, Jay B Shah, Jinliang Xing, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
April 22, 2015
Mitochondrial DNA Content as Risk Factor for Bladder Cancer and Its Association with Mitochondrial DNA Polymorphisms
Stephen B Williams, Yuanqing Ye, Maosheng Huang, et al.
Urology
|
September 19, 2006
Clinical model of lifetime cost of treating bladder cancer and associated complications
Elenir B C Avritscher, Catherine D Cooksley, H Barton Grossman, et al.
The Journal of Urology
|
October 16, 2007
Differences in survival among patients with sarcomatoid carcinoma, carcinosarcoma and urothelial carcinoma of the bladder
Jonathan L Wright, Peter C Black, Gordon A Brown, et al.
American Journal of Clinical Pathology
|
November 13, 2014
Uroplakin II is a more sensitive immunohistochemical marker than uroplakin III in urothelial carcinoma and its variants
Wenping Li, Yu Liang, Michael T Deavers, et al.
International Journal of Cancer
|
December 14, 2017
Dietary patterns and risk of recurrence and progression in non-muscle-invasive bladder cancer
Ellen Westhoff, Xifeng Wu, Lambertus A Kiemeney, et al.
Medicine
|
August 7, 2016
Comparison between whole mount tissue preparations and virtual tissue microarray samples for measuring Ki-67 and apoptosis indices in human bladder cancer: A cross-sectional study
Hisashi Oshiro, Bogdan A Czerniak, Kentaro Sakamaki, et al.
Page
of 21